可孚醫療(301087.SZ):擬出資1000萬元與專業投資機構共同投資基金
格隆匯8月16日丨可孚醫療(301087.SZ)公佈,公司與天津泓創企業管理諮詢合夥企業(有限合夥)、天津市永鈦海河賽達股權投資合夥企業(有限合夥)、北京沐仁投資管理有限公司、北京景達廣源科技發展有限公司、天津慶宇達科技有限公司、張媚釵、海南元生投資合夥企業(有限合夥)、天津市天使投資引導基金合夥企業(有限合夥)、天津市天開高教科創園創業種子基金合夥企業(有限合夥)、杭州泰鯤股權投資基金合夥企業(有限合夥)、天津天開九安海河海棠股權投資基金合夥企業(有限合夥)及陸瀟波簽署了《天津泓創海河創業投資合夥企業(有限合夥)有限合夥協議》,公司以自有資金增資天津泓創海河創業投資合夥企業(有限合夥)(簡稱“泓創海河”,相關基金以下簡稱“基金”)。泓創海河全體合夥人認繳出資總額為20,613萬元,公司認繳出資1,000萬元,認繳出資比例為4.85%。
泓創海河主要投資方向為醫療健康領域,與公司主營業務方向一致。本次投資將依託專業投資機構的團隊優勢、項目資源優勢和平台優勢,積極拓展投資渠道,推動公司產業佈局優化和戰略發展,提高公司綜合競爭能力,助力公司可持續發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.